🇺🇸 FDA
Patent

US 7692009

Reference standard for characterization of rosuvastatin

granted A61PA61P3/06

Quick answer

US patent 7692009 (Reference standard for characterization of rosuvastatin) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P3/06